Amiodarone has become an important drug for the treatment of supraventricular and
ventricular arrhythmias, in short-term inpatient and outpatient settings. It may also have a …

Amiodarone, a bi-iodinated benzofuran derivative, is, because of its high effectiveness, one
of the most widely used antiarrhythmic agents. However, adverse effects, especially …

Amiodarone, first used in Europe for the treatment of angina pectoris in the 1960s, began to
be widely utilized as an antiarrhythmic agent in the 1970s. Currently, it is one of the most …

Amiodarone, administered orally in doses of 200 to 600 mg/day, was remarkably effective in
the treatment and prevention of a wide variety of atrial and ventricular arrhythmias. Total …

Amiodarone is an iodinated benzofuran derivative, a highly lipophilic drug with
unpredictable pharmacokinetics. Although originally classified as a class III agent due to its …

Arrhythmias may be controlled in most patients with recurrent supraventricular tachycardia
or atrial fibrillation with small to moderate maintenance doses of amiodarone (100 to 400 …

Amiodarone is a potent antiarrhythmic agent that is used to treat ventricular arrhythmias and
atrial fibrillation. The drug prevents the recurrence of life-threatening ventricular arrhythmias …

Amiodarone has been associated with adverse events that may restrict its use. We
performed a meta-analysis of placebo-controlled trials to assess the relative risk of adverse …

A 73-year-old man with coronary artery disease, hypertension, and renal insufficiency
presents with recurrent, symptomatic atrial fibrillation despite a well-controlled ventricular …

Introduction: Amiodarone is the most widely used antiarrhythmic agent, with demonstrated
effectiveness against all the spectrum of cardiac tachyarrhythmias. The risk of adverse …